Pfizer Inc

NYSE : PFE

USA·Healthcare·Drug Manufacturers·Ordinary Shares

$29.58

−0.01 (−0.04%)Oct 16 close

Market Cap

$168.26B

Enterprise Value

$220.06B

P/E (TTM)

38.92

P/B

1.98

Net Cash / (Debt)

−$51.50B

52-Week Range

$24 — $30

5-Year Range

$22 — $61

Avg Volume (3M)

41.94M

Myovant Sciences Ltd and Pfizer Inc Collaboration To Develop and Commercialize Relugolix in Oncology and Women's Health Call Transcript

2020-12-28Corporate Presentation

Read the full earnings transcript with Waltermetrics Pro

The complete transcript text is available to Pro members.